Lentris 4mg Capsule is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment.
Lenvatinib
4mg
10s
Mylan Pharmaceuticals Pvt Ltd – A Viatris Company
Lorem ipsum dolor sit amet, consec tetur adipiscing elit.
+91 9373283509 / 9270190596
kaifh@jeffersonpharmaindia.com
S-2, Shivanjali, Friends Colony, Nagpur, Maharashtra – 440013.